414 related articles for article (PubMed ID: 11480718)
1. Pap smears in women with endometrial carcinoma.
Gu M; Shi W; Barakat RR; Thaler HT; Saigo PE
Acta Cytol; 2001; 45(4):555-60. PubMed ID: 11480718
[TBL] [Abstract][Full Text] [Related]
2. Peritoneal washings in endometrial carcinoma. A study of 298 patients with histopathologic correlation.
Gu M; Shi W; Barakat RR; Thaler HT; Saigo PE
Acta Cytol; 2000; 44(5):783-9. PubMed ID: 11015980
[TBL] [Abstract][Full Text] [Related]
3. How useful are cervical Pap smears in detecting endometrial carcinomas? A tertiary cancer center experience.
Mehta SP; Patel TS; Jana T; Samanta ST; Malvania R; Trivedi PP; Girdher S
Diagn Cytopathol; 2021 Jan; 49(1):127-131. PubMed ID: 32910561
[TBL] [Abstract][Full Text] [Related]
4. The Value of Papanicolaou Tests in the Diagnosis of Endometrial Carcinoma: A Large Study Cohort From an Academic Medical Center.
Serdy K; Yildiz-Aktas I; Li Z; Zhao C
Am J Clin Pathol; 2016 Mar; 145(3):350-4. PubMed ID: 27124917
[TBL] [Abstract][Full Text] [Related]
5. Association of Abnormal Pap Smear with Occult Cervical Stromal Invasion in Patients with Endometrial Cancer.
Khumthong K; Aue-Aungkul A; Kleebkaow P; Chumworathayi B; Temtanakitpaisan A; Nhokaew W
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2847-2850. PubMed ID: 31554386
[TBL] [Abstract][Full Text] [Related]
6. Value of histiocyte detection in Pap smears for predicting endometrial pathology. An institutional experience.
Nassar A; Fleisher SR; Nasuti JF
Acta Cytol; 2003; 47(5):762-7. PubMed ID: 14526675
[TBL] [Abstract][Full Text] [Related]
7. Positive predictive value of liquid-based and conventional cervical Papanicolaou smears reported as malignant.
Uyar DS; Eltabbakh GH; Mount SL
Gynecol Oncol; 2003 May; 89(2):227-32. PubMed ID: 12713984
[TBL] [Abstract][Full Text] [Related]
8. Endometrial adenocarcinoma with clinical evidence of cervical involvement: accuracy of diagnostic procedures, clinical course, and prognostic factors.
Leminen A; Forss M; Lehtovirta P
Acta Obstet Gynecol Scand; 1995 Jan; 74(1):61-6. PubMed ID: 7856435
[TBL] [Abstract][Full Text] [Related]
9. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
[TBL] [Abstract][Full Text] [Related]
10. Abnormal cervical cytology: a risk factor for endometrial cancer recurrence.
Brown AK; Gillis S; Deuel C; Angel C; Glantz C; Dubeshter B
Int J Gynecol Cancer; 2005; 15(3):517-22. PubMed ID: 15882179
[TBL] [Abstract][Full Text] [Related]
11. Does Cytological Laboratory Holds the Responsibility for the Low Sensitivity of the PAP Test in Detecting Endometrial Cancer?
Milicić V; Matić TS; Martinek V; Tomasković I; Ramljak V
Coll Antropol; 2015 Sep; 39(3):713-7. PubMed ID: 26898071
[TBL] [Abstract][Full Text] [Related]
12. Incidental finding of abnormal cervical pathology in hysterectomy specimens after normal preoperative Papanicolaou smears in Thammasat University Hospital.
Chundarat PA; Suwannarurk K; Bhamarapravatana K; Pattaraarchachai J; Thaweekul Y; Mairaing K; Poomtavorn Y
Asian Pac J Cancer Prev; 2014; 15(14):5811-4. PubMed ID: 25081705
[TBL] [Abstract][Full Text] [Related]
13. Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 1999 Sep; 74(3):385-94. PubMed ID: 10479498
[TBL] [Abstract][Full Text] [Related]
14. Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?
Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; McKee B; Hoskins WJ; Barakat RR
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):79-85. PubMed ID: 12182977
[TBL] [Abstract][Full Text] [Related]
15. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR
Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832
[TBL] [Abstract][Full Text] [Related]
16. Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era?
Subramaniam A; Fauci JM; Schneider KE; Whitworth JM; Erickson BK; Kim K; Huh WK
J Low Genit Tract Dis; 2011 Apr; 15(2):110-3. PubMed ID: 21263352
[TBL] [Abstract][Full Text] [Related]
17. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
[TBL] [Abstract][Full Text] [Related]
18. Endometrial carcinomas--flow cytometric DNA content and S-phase values.
Jacobsen M; Jakobsen A; Nedergaard L; Andersen JE; Nielsen K
Pathol Res Pract; 1997; 193(4):283-90. PubMed ID: 9258954
[TBL] [Abstract][Full Text] [Related]
19. [Cytological history of 148 women presenting with invasive cervical cancer].
Mubiayi N; Bogaert E; Boman F; Leblanc E; Vinatier D; Leroy JL; Querleu D
Gynecol Obstet Fertil; 2002 Mar; 30(3):210-7. PubMed ID: 11998209
[TBL] [Abstract][Full Text] [Related]
20. Detection rates and factors affecting thereof in endometrial hyperplasia, endometrial carcinoma, and cervical glandular lesions on cervical smear.
Ng JKM; Cheung BHC; Lee DHY; Li JJX; Ip PPC; Lee JHS; Yeung CSY; Yu MY
Cancer Med; 2023 Sep; 12(17):17581-17591. PubMed ID: 37501510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
